Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX1 | P07099 | 3/20 | 0.44 |
| ▸ | TRPM8 | Q7Z2W7 | 4/20 | 0.42 |
| ▸ | TRPA1 | O75762 | 2/20 | 0.42 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.36 |
| ▸ | TRPV1 | Q8NER1 | 4/20 | 0.35 |
| ▸ | HPGD | P15428 | 1/20 | 0.35 |
| ▸ | P2RX4 | Q99571 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL114683 | 0.84 | EPHX1 (0.46) | EPHX1TRPM8TRPA1CYP19A1ALDH1A1 | |
| SCHEMBL28350744 | 0.77 | EPHX1 (0.51) | EPHX1TRPM8TRPA1CYP19A1ALDH1A1 | |
| SCHEMBL9996875 | 0.77 | EPHX1 (0.45) | EPHX1TRPM8TRPA1CYP19A1ALDH1A1 | |
| SCHEMBL113449 | 0.77 | TRPM8 (0.48) | EPHX1TRPM8TRPA1CYP19A1ALDH1A1 | |
| SCHEMBL30537273 | 0.77 | EPHX1 (0.42) | EPHX1TRPM8TRPA1CYP19A1ALDH1A1 | |
| SCHEMBL1897804 | 0.77 | EPHX1 (0.42) | EPHX1TRPM8TRPA1CYP19A1ALDH1A1 | |
| SCHEMBL4594644 | 0.76 | EPHX1 (0.44) | EPHX1TRPM8TRPA1CYP19A1ALDH1A1 | |
| SCHEMBL29450387 | 0.76 | EPHX1 (0.44) | EPHX1TRPM8TRPA1CYP19A1ALDH1A1 | |
| SCHEMBL4455481 | 0.76 | EPHX1 (0.44) | EPHX1TRPM8TRPA1CYP19A1ALDH1A1 | |
| SCHEMBL21328419 | 0.74 | EPHX1 (0.40) | EPHX1TRPM8TRPA1CYP19A1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12128257-B2 | Extracts of Isochrysis sp | SYMRISE AG (DE) | 2024-10-29 | — | — | US | disclosed |
| CN-117355218-A | Flavor beads and methods of making and using the same | 威·曼父子有限公司 | 2024-01-05 | — | — | CN | disclosed |
| CN-116546890-A | Liquid composition comprising cereal beta-glucan or cereal extract containing beta-glucan | 西姆莱斯股份公司 | 2023-08-04 | — | — | CN | disclosed |
| CN-113543637-B | Antimicrobial mixture | 西姆莱斯股份公司 | 2023-07-14 | — | — | CN | disclosed |
| CN-113766911-A | Plant peptides and uses thereof (II) | 西姆莱斯股份公司 | 2021-12-07 | — | — | CN | disclosed |
| EP-3348255-B1 | EXTRACTS OF TETRASELMIS SP. FOR COSMETIC AND THERAPEUTIC PURPOSES | SYMRISE AG (DE) | 2021-11-10 | — | — | EP | disclosed |
| US-20200222730-A1 | Extracts of Isochrysis sp. | SYMRISE AG (DE) | 2020-07-16 | — | — | US | disclosed |
| CN-107410304-B | Compositions comprising benzyl alcohol derivatives and other antimicrobially active compounds | 西姆莱斯有限公司 | 2020-06-12 | — | — | CN | disclosed |
| US-10463891-B2 | Extracts of Isochrysis sp. | SYMRISE AG (DE) | 2019-11-05 | — | — | US | disclosed |
| EP-3348255-A1 | EXTRACTS OF TETRASELMIS SP. FOR COSMETIC AND THERAPEUTIC PURPOSES | Symrise AG (DE) | 2018-07-18 | — | — | EP | disclosed |
| US-20110152383-A1 | COMPOSITIONS COMPRISING BENZYL ALCOHOL DERIVATIVES AND FURTHER ANTIMICROBIAL ACTIVE COMPOUNDS | SYMRISE AG (DE) | 2011-06-23 | — | — | US | disclosed |
| EP-2306820-A2 | COMPOSITIONS COMPRISING BENZYL ALCOHOL DERIVATIVES AND FURTHER ANTIMICROBIAL ACTIVE COMPOUNDS | Symrise AG (DE) | 2011-04-13 | — | — | EP | disclosed |
| US-20100143267-A1 | EXTRACTS OF TETRASELMIS SP. | SYMRISE GMBH & CO. KG (DE) | 2010-06-10 | — | — | US | disclosed |
| EP-2193785-A2 | Extracts of Tetraselmis sp. for cosmetic and therapeutic purposes | Symrise GmbH & Co. KG (DE) | 2010-06-09 | — | — | EP | disclosed |
| US-20100080761-A1 | Extracts of Isochrysis sp. | SYMRISE GMBH & CO. KG (DE) | 2010-04-01 | — | — | US | disclosed |
| EP-2168570-A2 | Extracts of isochrysis sp. | Symrise GmbH & Co. KG (DE) | 2010-03-31 | — | — | EP | disclosed |
| WO-2010000877-A2 | FORMULATION WITH IRRITATION REDUCING ACTION COMPRISING BISABOLOL AND [6]-PARADOL | SYMRISE GMBH & CO. KG (DE) | 2010-01-07 | — | — | WO | disclosed |
| WO-2009101216-A2 | OMEGA-CYCLOHEXYLALKAN-1-OLES AND USE THEREOF AS ANTIMICROBIAL ACTIVES TO COMBAT BODY ODOR | SYMRISE GMBH & CO. KG (DE) | 2009-08-20 | — | — | WO | disclosed |
| US-20090123392-A1 | FRAGRANCE ACCORDS TO COMBAT THE PERCEPTION OF BODY ODOR | SYMRISE GMBH & CO. KG (DE) | 2009-05-14 | — | — | US | disclosed |
| WO-2008119841-A2 | COMPOSITIONS COMPRISING BENZYL ALCOHOL DERIVATIVES AND FURTHER ANTIMICROBIAL ACTIVE COMPOUNDS | SYMRISE GMBH & CO. KG (DE) | 2008-10-09 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110152383-A1 | COMPOSITIONS COMPRISING BENZYL ALCOHOL DERIVATIVES AND FURTHER ANTIMICROBIAL ACTIVE COMPOUNDS | UNC93B1, ECI1, IL4I1 | EPHX1 1050/4885TRPM8 2891/4885TRPA1 1527/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.